Scarica l'app Stockscreener
0.4725
1.34%
-0.0064
Dopo l'orario di chiusura:
.48
0.0075
+1.59%
Precedente Chiudi:
$0.4789
Aprire:
$0.48
Volume 24 ore:
134.01K
Relative Volume:
0.29
Capitalizzazione di mercato:
$12.05M
Reddito:
-
Utile/perdita netta:
$-29.80M
Rapporto P/E:
-0.3971
EPS:
-1.19
Flusso di cassa netto:
$-25.19M
1 W Prestazione:
-10.85%
1M Prestazione:
-2.50%
6M Prestazione:
-25.00%
1 anno Prestazione:
-37.91%
Intervallo 1D:
$0.46
$0.491
Intervallo di 1 settimana:
$0.445
$0.55
Portata 52W:
$0.384
$1.94
Sensei Biotherapeutics Inc Stock (SNSE) Company Profile
Nome
Sensei Biotherapeutics Inc
Settore
Industria
Telefono
(240) 243-8000
Indirizzo
1405 RESEARCH BLVD, SUITE 125, ROCKVILLE
Confronta SNSE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SNSE
Sensei Biotherapeutics Inc
|
0.4725 | 12.05M | 0 | -29.80M | -25.19M | -1.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.40 | 113.67B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
683.08 | 74.97B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
665.68 | 40.50B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
277.16 | 35.95B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
120.88 | 29.63B | 3.30B | -501.07M | 1.03B | -2.1146 |
Sensei Biotherapeutics Inc Stock (SNSE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-05-14 | Iniziato | Stephens | Overweight |
| 2021-07-01 | Downgrade | Berenberg | Buy → Hold |
| 2021-06-29 | Downgrade | Oppenheimer | Outperform → Perform |
| 2021-03-01 | Iniziato | Berenberg | Buy |
| 2021-03-01 | Iniziato | Citigroup | Buy |
| 2021-03-01 | Iniziato | Oppenheimer | Outperform |
| 2021-03-01 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Sensei Biotherapeutics Inc Borsa (SNSE) Ultime notizie
Sensei Biotherapeutics, Inc. Appoints Robert Pierce as Chief Scientific Officer; Opens its Boston Office - Marketscreener.com
Biotech Advances Breakthrough Cancer Treatment Results - Streetwise Reports
Sensei Biotherapeutics (NASDAQ:SNSE) Earns Buy Rating from HC Wainwright - Defense World
Sensei Biotherapeutics faces Nasdaq delisting risk By Investing.com - Investing.com Australia
Sensei Biotherapeutics Provides Corporate Update and Highlights Key Upcoming Milestones - The Manila Times
Sensei Bio's Cancer Drug Shows Promise in Phase 1/2 Trial, Enrolls 45 Patients for VISTA Study - StockTitan
Sensei Biotherapeutics faces Nasdaq delisting risk - Investing.com
Sensei Biotherapeutics to Participate in Citi’s 2024 Global Healthcare Conference - GlobeNewswire
Sensei Biotherapeutics Q3 2024 Results and Strategic Moves - TipRanks
Layoff Tracker: Sensei to Cut 46% of Workforce, Close Research Site - BioSpace
Sensei Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewswire
Sensei Biotherapeutics Inc. (SNSE) Quarterly 10-Q Report - Quartzy
Sensei Bio Cuts 46% of Workforce, Extends Cash Runway to 2026 Amid Restructuring | SNSE Stock News - StockTitan
Sensei Biotherapeutics Inc (SNSE) Quarterly 10-Q Report - Quartz
Sensei Biotherapeutics to Present at Two Upcoming Scientific Conferences - GlobeNewswire
3 US Penny Stocks To Monitor In October 2024 - Yahoo Finance Australia
Why iRhythm Technologies Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - Benzinga
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.01% - MSN
Sensei Biotherapeutics (NASDAQ:SNSE) Stock Price Up 6% - Defense World
Sensata Technologies Holding plc (NYSE:ST) Stock Holdings Trimmed by Mutual of America Capital Management LLC - Defense World
SeQuent Scientific hits 52-week high, surges nearly 9% in 20 minutes - Business Upturn
SENS Stock on the Rise: A Promising Investment - The InvestChronicle
Oman India Investment Fund sells shares worth Rs 75 cr in Senco Gold - The Economic Times
Latest News | Oman India Investment Fund Sells Shares Worth Rs 75 Cr in Senco Gold - LatestLY
Sensiva Health names Ben Williamson as Chief Executive Officer - WV News
Recent Insider Activity Could Benefit Sensata Technologies Holding Plc (ST) - Knox Daily
Is Seelos Therapeutics Inc (SEEL) worth investing in despite its undervalued state? - US Post News
Federated Hermes Inc. Increases Holdings in Sensata Technologies Holding plc (NYSE:ST) - Defense World
46,650 Shares in Sensata Technologies Holding plc (NYSE:ST) Purchased by Schwerin Boyle Capital Management Inc. - Defense World
Trend Tracker for (ST) - Stock Traders Daily
Benjamin Edwards Inc. Buys 169 Shares of Standex International Co. (NYSE:SXI) - Defense World
Sensei Biotherapeutics names new financial chief - Investing.com India
Senseonics (NYSE:SENS) Now Covered by Analysts at StockNews.com - Defense World
Sensei Biotherapeutics Appoints New Financial Chief - TipRanks
Are Smart Investors Making the Right Decision? Sensata Technologies Holding Plc (ST) - SETE News
Moors & Cabot Inc. Acquires 8,900 Shares of Sensata Technologies Holding plc (NYSE:ST) - Defense World
Sensei Biotherapeutics names new financial chief By Investing.com - Investing.com South Africa
Sensata Technologies (NYSE:ST) Releases Q3 2024 Earnings Guidance - Defense World
Multibagger Alert: Senco Gold Stock Soars 300% Since IPO – Is More Growth on the Horizon? Analysts Weigh In! - Share Price India News
SYSTM Wealth Solutions LLC Lowers Position in Sensata Technologies Holding plc (NYSE:ST) - Defense World
Closing Bell Recap: Seelos Therapeutics Inc (SEEL) Ends at 0.20, Reflecting a -11.51 Downturn - The Dwinnex
Sensei Biotherapeutics’ SNS-103 shows pH-dependent antitumor efficacy - BioWorld Online
Massachusetts Financial Services Co. MA Sells 444,049 Shares of Sensata Technologies Holding plc (NYSE:ST) - Defense World
There is no doubt that Seelos Therapeutics Inc (SEEL) ticks all the boxes. - SETE News
Ratios Reveal: Breaking Down SenesTech Inc (SNES)’s Financial Health - The Dwinnex
Multibagger Stock: Senco Gold share price jumps over 300% from its IPO price in over 14 months. More steam left? - MSN
ST Stock Sees Surge of Approximately 2.46% in Last Five Days - Knox Daily
Multibagger Stock: Senco Gold share price jumps over 300% from its IPO price in over 14 months. More steam left? | Stock Market News - Mint
Seneca Foods stock soars to 52-week high, hits $64 mark - Investing.com
Investing in Senseonics Holdings Inc (SENS): What You Must Know - Knox Daily
Seelos Therapeutics Inc (SEEL) Stock: A Comprehensive 52-Week Review - The InvestChronicle
Sensei Biotherapeutics Inc Azioni (SNSE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.49%
0.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):